Is evaluation of pharmacokinetic properties required for vaccines such as Revaxis?

iatroX medicinesPublished 8 November 2026

The answer

Answer

No, evaluation of pharmacokinetic properties is not required for vaccines such as Revaxis.

REVAXISSANOFI · emc · SmPC §5.2 Pharmacokinetic properties · Version 18Document updated 24 February 2025

Sources checked 8 November 2026

loading page…

learn & practise

clinical reference

trust & support

legal

diphtheria, tetanus and poliomyelitis · Medicine question

iatroX medicinesPublished 8 November 2026

The answer

No, evaluation of pharmacokinetic properties is not required for vaccines such as Revaxis.

REVAXISSANOFI · emc · SmPC §5.2 Pharmacokinetic properties · Version 18Document updated 24 February 2025

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

Read the wider context, including uses, precautions and the sources behind this medicine guide.